Jacobio Pharma lines up Hong Kong IPO

Jonathan Breen

November 30, 2020 08:30 am

Healthcare medical biopharmaceutical investing stock chart background | Kurhan - stock.adobe.com

Jacobio Pharmaceuticals is preparing to launch the roadshow for its Hong Kong IPO after winning approval to list from the city’ stock exchange last week.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Equity IPOs Health and Biotech Equity China China International Capital Corp Hong Kong SAR Asia Greater China Northeast Asia Asia Pacific Emerging Markets SRI Goldman Sachs

JB

Jonathan Breen

Equities editor GlobalCapital Asia